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Abstract
Deep brain stimulation has been put forward as a potential “cure” for intractable drug addiction. This
is largely based on preclinical studies in animal models of addiction and small case series of positive,
but short-term, effects on addictive behaviour in highly selected individuals. The history of
neurosurgical treatment for psychiatric disorders suggests that we should be cautious in prematurely
advocating invasive neurosurgical procedures on the basis of such limited evidence. Further research
is required in animal models of addiction and in people treated for other neurological or psychiatric
disorders before trials in addicted populations can be justified.
Addictive disorders are among the most common mental
disorders in many developed countries. Although many
of these disorders remit without treatment in young
adulthood, under the influence of increased responsi-
bilities of marriage, mortgages, and children, addiction
can become chronic and relapsing. People with more
severe forms of addiction often seek help from specialist
addiction and mental health services when they are in
their early 30s. Psychosocial and pharmacological
treatments can reduce the severity of problems in many
cases but enduring abstinence can be difficult to sustain.
Unresolved addiction lies at the heart of many social ills,
sometimes driving people into crime or prostitution in
order to support their habit, or onto the streets when
they fall prey to it.
Advocates of trials of deep brain stimulation in addiction
argue that it is a potentially useful treatment for cases
that fail to respond to existing treatments, citing evidence
from preclinical and clinical studies. Deep brain stimula-
tion is a neurosurgical intervention that has been used to
treat intractable movement disorders in patients with
Parkinson’s disease. The technique uses a surgically
implanted, battery-operated neurostimulator—a bit like
a pacemaker—to deliver electrical stimulation that
modulates electrical signals in targeted areas of the
brain. The neurostimulator is normally implanted under
the skin near the collarbone and connected to electrodes
extending through a small hole in the skull to the desired
brain area. The device can be removed at a later date.
Deep brain stimulation is currently being trialled in the
treatment of intractable psychiatric disorders such as
Tourette’s syndrome, obsessive compulsive disorder
(OCD), and depression [1]. In this article, we review
the evidence used to advocate the use of deep brain
stimulation in the treatment of intractable addiction [2].
The case for trialling deep brain stimulation
First, neuroscience research on animals and human
neuroimaging studies have identified the brain reward
circuits involved in drug effects and addiction. What’s
more, researchers have been able to reduce self-admin-
istration of addictive drugs in animals by stimulating or
ablating these regions in the dopaminergic reward
pathway (see [3]).
Second, there are case studies in which deep brain
stimulation has reduced addictive behaviour in patients
treated for Parkinson’s disease. Two patients with
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were able to overcome the compulsive use of their
dopamine replacement therapy [4]. Similarly, Parkin-
son’s disease patients who developed gambling pro-
blems or hypersexuality while taking dopamine
replacement therapy have reported that these disorders
disappear following deep brain stimulation treatment
[5]. These observations are supported by small case series
in which deep brain stimulation has reportedly reduced
addiction to nicotine, alcohol, and heroin in patients
treated for other disorders [6-8]. For example, a woman
whose agoraphobia was unsuccessfully treated by
bilateral deep brain stimulation of the nucleus accum-
bens reported improvements in her alcohol dependence
[8]. The same group conducted a retrospective study of
ten smokers who underwent deep brain stimulation of
the nucleus accumbens for Tourette’s syndrome, OCD,
or anxiety and found that three had stopped smoking
[7]. The variability of this sample and their intention to
quit makes interpreting this study difficult.
This evidence is supported by the apparently successful
neurosurgical ablation of the nucleus accumbens for
heroin addiction by Chinese neurosurgeons [9]. There is
also one report in which deep brain stimulation of the
nucleus accumbens greatly reduced alcohol craving and
consumption in three long-term, treatment-refractory,
alcohol-dependent individuals; two were abstinent after
one year and a third had markedly reduced their drinking
[10,11].
The case for caution
First, there are important differences between the case for
deep brain stimulation in Parkinson’s disease and that
for addiction. Patients with Parkinson’s disease who no
longer respond to dopamine replacement treatment face
a course of irreversible deterioration in motor function
and increasing disability. In contrast, addiction does not
usually follow an inexorable path to severe disability and
death; it is generally more amenable to pharmacological
and psychotherapeutic treatment, so drastic remedies are
less justifiable. In fact, many of the failures of addiction
treatment are due to inadequate access to well-run and
optimally provided forms of existing treatments; a
situation that could be exacerbated by an increased use
of deep brain stimulation to treat drug addiction.
Second, the history of neurosurgical treatment in psychia-
trycautionsagainstuncriticallyaccepting“positiveresults”
from uncontrolled and often selectively reported clinical
case series [3]. For example, the two case reports of
Parkinson’s disease patients successfully treated with deep
brain stimulation for dopamine dysregulation syndrome
[4] need to be balanced against a larger study that found
that12of17suchpatientswereunimprovedorworseafter
deep brain stimulation [12]. Deep brain stimulation has
also been reported to induce addictive behaviour in some
cases [13]. And while ablative neurosurgery for heroin
addiction reduced drug use in some patients in the short
term, subsequent long-term follow-up found that it
carried significant side effects and was not as effective as
first thought [1]. These published case studies provide a
weakevidencebasetoassessthesafetyandefficacyofdeep
brain stimulation in addiction [3].
Third, deep brain stimulation is often described as a
“reversible” alternative to neurosurgery, but it is none-
theless an invasive intervention that carries significant
risks [14]: 11% of patients have adverse events from
surgery and 4% of Parkinson’s disease patients suffer
intracerebral haemorrhages [15]. Insertion of stimulating
electrodes can cause serious infections and produce
cognitive, behavioural, and emotional disturbances [15].
It can also produce irreversible psychosocial changes that
can be harmful [14]. For the use of deep brain
stimulation in the treatment of addiction to be justified,
the benefit of the treatment needs to outweigh the
damage that it may cause and the negative consequences
of not providing the treatment. Evidence suggests that
the very uncertain benefits of deep brain stimulation in
alleviating the symptoms of addiction do not outweigh
the known harms associated with the procedure, or the
harm of not providing deep brain stimulation (on the
assumption that other currently available treatments are
provided to the highest standard) [16].
Fourth, deep brain stimulation for addiction is an
expensive form of treatment for addictive disorders
where access to existing treatment remains poor.
Inability to pay for treatment and stigmatisation often
discourage addicted persons from seeking treatment. An
expensive neurosurgical treatment that costs around
US$50,000 (with maintenance costs of approximately
US$10,000 over the next few years) will utilise scarce
health resources to treat a very small number of addicted
patients with the income to pay for it, while failing to
treat the majority.
When may a trial of deep brain stimulation be
warranted in addiction?
For trials of deep brain stimulation to be justifiable in
patients with addiction, the following requirements need
to be met. First, there needs to be strong evidence that
any participants in such trials suffer from a severely
debilitating form of addiction that carries a high risk of
morbidity or premature death and that has not
responded to adequate trials of effective treatments.
Second, there needs to be a reasonable expectation that
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This should include preclinical evidence of likely benefit,
evidence on the long-term effects of deep brain stimula-
tion on patients with other psychiatric conditions (e.g.,
OCD and depression), and a good theoretical basis for
stimulating the targeted brain region.
Accordingly, we believe that it would be premature to
trial deep brain stimulation in the treatment of addiction
on the basis of available animal models, the small
number of selected case studies, and the evidence from
uncontrolled studies of neurosurgery for heroin addic-
tion. We have outlined above the type of research in
animals and individuals required to make a case for
undertaking trials of deep brain stimulation in the future
[3]. We also support calls for the creation of a register of
allcasestreated with deepbrain stimulation,assuggested
recently [17], to minimise the potential of selective
publication of good outcomes. However, even if these
conditions are met and deep brain stimulation proves to
be safe and effective in treating addiction, we suggest that
the high costs involved make it a lower priority for public
funding than trials of pharmacotherapies.
Abbreviation
OCD, obsessive compulsive disorder.
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